← Open Payments lookup

LINDSAY LEHECHKA: Open Payments

NPI 1942833256 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$602 in 33 payments from 15 companies in 2025. Trend: 2023 $881 · 2024 $877 · 2025 $602

Food & beverage: $602
CompanyPaymentsAmount
ABBVIE INC.13$184
Novo Nordisk Inc2$114
Lilly USA, LLC3$57
AstraZeneca Pharmaceuticals LP3$47
Forte Bio-Pharma LLC2$31
Ascendis Pharma Endocrinology Inc1$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$21
Boehringer Ingelheim Pharmaceuticals, Inc.1$20
Sumitomo Pharma America, Inc.1$20
Amgen Inc.1$19

Products named: Ozempic, QULIPTA, VRAYLAR, MOUNJARO, UBRELVY, AIRSUPRA, PROLATE, Yorvipath.

Industry payments across KS — which companies pay providers there.